ST3GAL6 and thymoma: Furthermore, the clinical data showed that high expression level of B3GNT5 in thymoma was associated with worse disease-free survival (p < 0.05, HR = 0.3339, 95%CI 0.1204-0.9263), while ST3GAL6 expression didn't influence DFS (p > 0.05, HR = 1.995, 95%CI 0.7339-5.424) (Fig. 8).